A detailed history of Allspring Global Investments Holdings, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 1,746 shares of CDXC stock, worth $9,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,746
Holding current value
$9,585
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$2.51 - $3.8 $4,382 - $6,634
1,746 New
1,746 $6,000
Q2 2022

Jul 25, 2022

SELL
$1.59 - $2.7 $117,923 - $200,248
-74,166 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$2.02 - $3.92 $10,903 - $21,160
-5,398 Reduced 6.78%
74,166 $182,000
Q4 2021

Jan 28, 2022

BUY
$3.74 - $6.7 $297,569 - $533,078
79,564 New
79,564 $297,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.